Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 41% ± 22% | |
lung | 13 studies | 23% ± 6% | |
peripheral blood | 11 studies | 23% ± 6% | |
eye | 7 studies | 31% ± 11% | |
kidney | 5 studies | 20% ± 3% | |
bone marrow | 4 studies | 21% ± 4% | |
heart | 4 studies | 24% ± 4% | |
liver | 4 studies | 34% ± 14% | |
intestine | 4 studies | 24% ± 9% | |
adipose | 4 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4340.18 | 1445 / 1445 | 100% | 19.26 | 183 / 183 |
brain | 100% | 3723.38 | 2639 / 2642 | 100% | 13.82 | 705 / 705 |
prostate | 100% | 3924.81 | 245 / 245 | 100% | 14.40 | 501 / 502 |
breast | 100% | 4387.66 | 459 / 459 | 100% | 19.85 | 1114 / 1118 |
ovary | 100% | 4672.17 | 180 / 180 | 100% | 11.86 | 428 / 430 |
thymus | 100% | 4748.12 | 653 / 653 | 99% | 14.81 | 601 / 605 |
lung | 100% | 3500.21 | 576 / 578 | 100% | 13.52 | 1151 / 1155 |
uterus | 100% | 4786.49 | 170 / 170 | 99% | 11.69 | 455 / 459 |
bladder | 100% | 4477.33 | 21 / 21 | 98% | 10.35 | 495 / 504 |
pancreas | 100% | 2120.58 | 327 / 328 | 98% | 9.94 | 175 / 178 |
stomach | 100% | 3095.70 | 359 / 359 | 98% | 13.08 | 280 / 286 |
intestine | 100% | 4466.91 | 966 / 966 | 98% | 11.41 | 514 / 527 |
kidney | 100% | 2868.42 | 89 / 89 | 97% | 11.54 | 875 / 901 |
adrenal gland | 100% | 3948.58 | 258 / 258 | 94% | 10.09 | 217 / 230 |
skin | 100% | 4821.92 | 1808 / 1809 | 93% | 12.90 | 441 / 472 |
liver | 100% | 2393.00 | 226 / 226 | 92% | 6.56 | 374 / 406 |
adipose | 100% | 4123.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4576.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 9633.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2994.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.33 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.05 | 28 / 29 |
heart | 96% | 3685.93 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 7.17 | 63 / 80 |
peripheral blood | 45% | 1780.45 | 419 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0000209 | Biological process | protein polyubiquitination |
GO_2000058 | Biological process | regulation of ubiquitin-dependent protein catabolic process |
GO_1990416 | Biological process | cellular response to brain-derived neurotrophic factor stimulus |
GO_0001541 | Biological process | ovarian follicle development |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_0035037 | Biological process | sperm entry |
GO_0061002 | Biological process | negative regulation of dendritic spine morphogenesis |
GO_0060736 | Biological process | prostate gland growth |
GO_1905528 | Biological process | positive regulation of Golgi lumen acidification |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0042220 | Biological process | response to cocaine |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0006508 | Biological process | proteolysis |
GO_0007420 | Biological process | brain development |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_0035641 | Biological process | locomotory exploration behavior |
GO_0061743 | Biological process | motor learning |
GO_0048511 | Biological process | rhythmic process |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0032570 | Biological process | response to progesterone |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000502 | Cellular component | proteasome complex |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | UBE3A |
Protein name | Ubiquitin protein ligase E3A Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54) Ubiquitin-protein ligase E3A (EC 2.3.2.26) HECT-type E3 ubiquitin transferase (EC 2.3.2.26) |
Synonyms | hCG_18679 EPVE6AP E6AP HPVE6A |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates . Several substrates have been identified including the BMAL1, ARC, LAMTOR1, RAD23A and RAD23B, MCM7 (which is involved in DNA replication), annexin A1, the PML tumor suppressor, and the cell cycle regulator CDKN1B . Additionally, may function as a cellular quality control ubiquitin ligase by helping the degradation of the cytoplasmic misfolded proteins . Finally, UBE3A also promotes its own degradation in vivo. Plays an important role in the regulation of the circadian clock: involved in the ubiquitination of the core clock component BMAL1, leading to its proteasomal degradation . Acts as transcriptional coactivator of progesterone receptor PGR upon progesterone hormone activation . Acts as a regulator of synaptic development by mediating ubiquitination and degradation of ARC (By similarity). Required for synaptic remodeling in neurons by mediating ubiquitination and degradation of LAMTOR1, thereby limiting mTORC1 signaling and activity-dependent synaptic remodeling (By similarity). Synergizes with WBP2 in enhancing PGR activity . .; FUNCTION: (Microbial infection) Catalyzes the high-risk human papilloma virus E6-mediated ubiquitination of p53/TP53, contributing to the neoplastic progression of cells infected by these viruses. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. . |
Accessions | A0A0G2JQQ5 Q96GR7 ENST00000628733.2 ENST00000675177.1 A0A0D9SES7 A0A1B0GTB3 ENST00000604860.3 ENST00000629886.2 ENST00000638155.1 [Q05086-2] ENST00000636667.1 ENST00000628267.2 A0A6Q8PHE5 Q9H2G0 Q5W7F7 ENST00000629252.2 ENST00000637886.1 [Q05086-3] A0A0D9SG54 ENST00000625778.3 ENST00000638011.1 [Q05086-2] ENST00000630907.2 Q9UBN9 ENST00000630424.2 [Q05086-2] A0A1B0GVL3 A0A0D9SG63 ENST00000625681.2 A0A0D9SG77 A0A0D9SFU3 ENST00000438097.6 [Q05086-2] S4R306 ENST00000566215.5 [Q05086-2] ENST00000648336.2 [Q05086-3] ENST00000626589.2 ENST00000650110.1 [Q05086-1] ENST00000635914.1 ENST00000649550.1 [Q05086-2] Q9BUI6 ENST00000626176.2 ENST00000628890.1 A0A0D9SF91 Q05086 A0A0D9SFH3 ENST00000428984.6 [Q05086-2] A0A0D9SEJ2 |